IM19 CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus (SLE)

NCT06513429 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Refractory Systemic Lupus Erythematosus

Interventions

BIOLOGICAL: IM19 CAR-T cells

Sponsor

Peking University Third Hospital